Involving Communities in Deciding What Benefits They Receive in Multinational Research

Journal of Medicine and Philosophy (United Kingdom)

Volumn 40, Issue 5, 2015, Pages 584-600

  Wendler, David ^a   Shah, Seema ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

benefits; clinical research; exploitation; risks

Indexed keywords

COMMUNITY PARTICIPATION; DEVELOPED COUNTRY; ETHICS; HEALTH CARE ACCESS; HUMAN; HUMAN RIGHTS; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PHILOSOPHY; PROCEDURES; PSYCHOLOGY; RESIDENCE CHARACTERISTICS; SOCIAL JUSTICE;

BIOMEDICAL RESEARCH; COMMUNITY PARTICIPATION; DEVELOPING COUNTRIES; ETHICS; HEALTH SERVICES ACCESSIBILITY; HUMAN RIGHTS; HUMANS; PHILOSOPHY, MEDICAL; RESIDENCE CHARACTERISTICS; SOCIAL JUSTICE;

EID: 84943520945     PISSN: 03605310     EISSN: 17445019     Source Type: Journal    
DOI: 10.1093/jmp/jhv017     Document Type: Article

References (29)

1. Angell, M. 1997. The ethics of clinical research in the third world. New England Journal of Medicine 337:847-49.
2. Annas, G. J. and M. A. Grodin. 1998. Human rights and maternal-fetal HIV transmission prevention trials in Africa. American Journal of Public Health 88:560-63.
3. Arneson, R. J. 2011. Review of Exploitation by Alan Wertheimer. Mind 110:888-91.
4. Arras, J. D. 2004. Fair benefits in international medical research. Hastings Center Report 34:3.
5. Ballantyne, A. 2008. "Fair benefits" accounts of exploitation require a normative principle of fairness: Response to Gbadegesin and Wendler, and Emanuel et al. Bioethics 22:239-44.
6. -. 2010. How to do research fairly in an unjust world. American Journal of Bioethics 10:26-35.
7. CIOMS. 2002. Commentary on Guideline 15, International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva, Switzerland: Council for International Organizations of Medical Sciences.
8. Cleaton-Jones, P. E. 1997. An ethical dilemma: Availability of anti-retroviral therapy after clinical trials with HIV infected patients are ended. British Medical Journal 314:887-88.
9. Gbadegesin, S. and D. Wendler. 2006. Protecting communities in health research from exploitation. Bioethics 20:248-53.
10. Griffin, J. 1988. Well-Being: Its Meaning, Measurement, and Moral Importance. Oxford: Oxford University Press.
11. Hughes, R. 2012. Justifying community benefit requirements in international research. American Journal of Bioethics 28:397-404.
12. Jonas, H. 1969. Philosophical reflections on experimenting with human subjects. Daedalus: The Journal of the American Academy of Arts and Sciences 98:219-47.
13. Lavery, J. V., S. V. S. Bandewar, J. Kimani, R. E. G. Upshur, F. A. Plummer, and P. A. Singer. 2010. "Relief of oppression:" An organizing principle for researchers' obligations to participants in observational studies in the developing world. BMC Public Health 10:384.
14. London, A. J. and K. J. S. Zollman. 2010. Research at the auction block: Problems for the Fair Benefits Approach to international research. Hastings Center Report 40:34-45.
15. Lurie, P. and S. M. Wolfe. 1997. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. New England Journal of Medicine 337:853-56.
16. Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries. 2002. Fair benefits for research in developing countries. Science 298:2133-34.
17. -. 2004. Moral standards for research in developing countries: From "reasonable availability" to "fair benefits." Hastings Center Report 34:17-27.
18. Phillips, T. 2011. From the ideal market to the ideal clinic: Constructing a normative standard of fairness for human subjects research. Journal of Medicine and Philosophy 36:79-106.
19. Raz, J. 1986. The Morality of Freedom. Oxford: Oxford University Press.
20. Shapiro, H. T. and E. M. Meslin. 2001. Ethical issues in the design and conduct of clinical trials in developing countries. New England Journal of Medicine 345:139-42.
21. Tarantola, D., R. Macklin, Z. H. Reed, M. P. Kieny, S. Osmanov, M. Stobie, and C. Hankins. 2007. Ethical considerations related to the provision of care and treatment in vaccine trials. Vaccine 25:4863-74.
22. Tucker, T. and C. Slack. 2003. Not if but how? Caring for HIV-1 vaccine trial participants in South Africa. Lancet 362:995.
23. UNAIDS. 2011. Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS [Online]. Available: http://www.unaids.org/sites/default/files/media-asset/JC1853-GPP-Guidelines-2011- en-0.pdf (accessed June 17, 2015).
24. Varmus, H. and D. Satcher. 1997. Ethical complexities of conducting research in developing countries. New England Journal of Medicine 337:1003-05.
25. Weijer, C. and E. J. Emanuel. 2000. Protecting communities in biomedical research. Science 289:114-44.
26. Wertheimer, A. 1996. Exploitation. Princeton, NJ: Princeton University Press.
27. Wertheimer, A., J. Millum, and G. O. Schaefer. 2010. Why adopt a maximin theory of exploitation? American Journal of Bioethics 10:38-39.
28. World Medical Association. 2008. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. New York: World Medical Association.
29. World Medical Association. 2013. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. New York: World Medical Association.